Menu
VIPGroup

Operational Improvement Consulting  

Lean Enterprise | Lean Manufacturing | Lean Supply Chain | Lean Regulatory Compliance
| Lean Six Sigma | Lean Leadership & Coaching | Lean Office 

(847) 566-7740
  • Home
  • Services
    • Lean System for Management
    • Leadership & Coaching
    • Lean Enterprise
    • Lean For Manufacturing
    • Lean Supply Chain
    • Six Sigma
    • Regulatory & Compliance
    • Lean Office
    • Pharmacovigilance
    • Lean Healthcare
    • Digital Factory
    • Lean Retail
  • Expertise
    • VIP Lean Manufacturing Key Elements
    • Pharmacovigilance Approach
    • Lean And Six Sigma Approach
    • Lean Consultants
    • Contact VIPGroup
  • Articles
    • Covid 19 Implications for Business - Human Resources
    • Covid 19 Implications for Business Supply Chain
    • Covid 19 Implications for your Work Stations
    • Leading in New Ways
    • The Isolated Executive
    • Where Leaders Prevail and Managers Fail
    • Quality Part 1
      • Quality Part 2
    • Lean Supply Chain
    • Maintenance Versus Production
    • Project Management
      • Project Management Page 2
    • Lean Transformation
      • Employee Engagement
    • Lean Enterprise
      • Lean Enterprise Part 2
    • Lean Performance Measurement Systems
      • Lean Performance Measurement Systems Part 2
    • Lean Pharmacovigilance
      • Compliant Operations
    • Lean Leadership
    • Lean Office
  • Our Clients
    • Client Testimonials
    • Case Studies
  • About
    • Our Code of Ethics
    • Sexual Harrassment Policy
  • Contact
    • Employment Opportunities
  • Lean Enterprise
  • Home
  • Services
    • Lean System for Management
    • Leadership & Coaching
    • Lean Enterprise
    • Lean For Manufacturing
    • Lean Supply Chain
    • Six Sigma
    • Regulatory & Compliance
    • Lean Office
    • Pharmacovigilance
    • Lean Healthcare
    • Digital Factory
    • Lean Retail
  • Expertise
    • VIP Lean Manufacturing Key Elements
    • Pharmacovigilance Approach
    • Lean And Six Sigma Approach
    • Lean Consultants
    • Contact VIPGroup
  • Articles
    • Covid 19 Implications for Business - Human Resources
    • Covid 19 Implications for Business Supply Chain
    • Covid 19 Implications for your Work Stations
    • Leading in New Ways
    • The Isolated Executive
    • Where Leaders Prevail and Managers Fail
    • Quality Part 1
      • Quality Part 2
    • Lean Supply Chain
    • Maintenance Versus Production
    • Project Management
      • Project Management Page 2
    • Lean Transformation
      • Employee Engagement
    • Lean Enterprise
      • Lean Enterprise Part 2
    • Lean Performance Measurement Systems
      • Lean Performance Measurement Systems Part 2
    • Lean Pharmacovigilance
      • Compliant Operations
    • Lean Leadership
    • Lean Office
  • Our Clients
    • Client Testimonials
    • Case Studies
  • About
    • Our Code of Ethics
    • Sexual Harrassment Policy
  • Contact
    • Employment Opportunities
  • Lean Enterprise

​Pharmacovigilance

Pharmacovigilance Methodology

An ongoing assessment of the benefit-risk profile of products based on the collection and collation of reports of adverse events, from whatever the source.

Adverse Event (AE)

Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a casual relationship with its treatment. An AE can therefore be any unfavorable and unintended sign, symptom or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product.

Serious Adverse Event (SAE)

Any untoward medicinal occurrence that at any dose:  
  • Results in death
  • Is life threatening
  • Requires hospitalization
  • or prolongation of existing hospitalization
  • Results in persistent or significant disability, incapacity 

Pharmacovigilance ​Process Flow

  • Collect and collate AE reports from clinical trials
  • Collect and collate Spontaneous AE reports from consumers and health professionals
  • Collect and collate AE reports from literature sources and regulatory authorities
  • Assess the seriousness and expectations of the reports
  • Enter the data into a suitable central databaseProvide a medical evaluation of the report
  • Provide an analysis of similar events for expedited reports
  • Ensure that reporting timelines for expedited reports are met

Adverse Events Include

  • Exacerbation of a preexisting illness
  • Increased frequency or severity of a pre-existing condition
  • Condition diagnosed after study drug initiated
  • Continuous or persistent symptom or disease present at baseline which worsens

FDA Reporting Requirements

  • Serious: 15-day written IND Safety Report: Unexpected - Drug related
  • Serious-Fatal: 7-day Phone or Fax Report: Unexpected-Drug related-Life threatening or Fatal

Lean Principles for Case Handling

Lean Process Case Handling Pharmacovigilance Methodology

Process

​Efficient & Streamlined
Simple & Visible
Harmonized Across Departments
Right First Time Approach
Agreed Business Rules

Standards

​Consistent
Simple & Readable
Understood by All

External

​Compliance
Quality Assessments
Gain Regulators Confidence

Pharmacovigilance

​Proactive
Active Communications
Best Methods Used
Involvement of All Units
Signals Detected & Evaluated 

Systems

​One Global Database
Transparent Tracking
Reduction of Duplication

People

​Correct Number
Training on the Process
Orientation in Lean 

Organizational Structure

​Process Aligned
Aligned Priorities, Roles and Responsibilities
Communication, Co-operation, Co-ordination and Empowerment

Performance Measurement

​Focused on Thoroughness, Integrity, Timely
Simple and Visible 
Aligned Targets, Rewords and Recognition
Home
Services
Expertise
Articles
About
Contact
For information about how the VIPGroup can assist your program call 847.910.6335 or Contact Us directly.
Picture
© Value Innovation Partners LTD. 2022 All Rights Reserved

Chicago
Boston
Europe
Singapore
​

Picture
Picture
Picture